• Pyridostatin: A Structure-First Assay Strategy

  2026-09-21

  Pyridostatin is more than a telomere-directed G-quadruplex probe. This article presents a structure-first framework for separating DNA effects, emerging RNA G-quadruplex biology, and TDP-43 assay readouts.

• Imatinib (STI571) for PDGFR Kinase Workflows

  2026-09-20

  Imatinib (STI571) provides a practical pharmacological handle for interrogating Abl, c-Kit, and PDGF receptor signaling in cell-based and biochemical assays. This workflow-focused guide shows how to benchmark pathway inhibition, reproduce PDGF-driven remodeling models, and troubleshoot exposure, readout, and selectivity problems.

• Perospirone: Reframing Antipsychotic Mechanisms

  2026-09-19

  Perospirone is best known for coordinated 5-HT2A, D2, and 5-HT1A pharmacology, but new evidence identifies concentration-dependent inhibition of vascular Kv1.5-associated currents. This article translates that finding into a practical framework for schizophrenia research, neuropsychiatric disorder models, and cardiovascular safety studies.

• Ribociclib succinate: Reliable CDK4/6 Assays

  2026-09-18

  A scenario-based guide to using Ribociclib succinate (SKU B1084) in cell proliferation, viability, and cell-cycle experiments. It connects formulation data, pH behavior, assay controls, and vendor-selection criteria to more interpretable cancer research workflows.

• Tankyrase Inhibition, YAP, and HCC Growth

  2026-09-18

  Jia et al. showed that the tankyrase inhibitors XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity and stabilizing the YAP regulators AMOTL1 and AMOTL2. The study’s main contribution is to connect tankyrase inhibition with Hippo pathway control, extending mechanistic interpretation beyond the canonical Wnt/β-catenin framework.

• Cell Senescence β-Galactosidase Staining Kit Workflow

  2026-09-17

  Convert SA-β-Gal activity into a practical brightfield endpoint for macrophage inflammation studies, aging models, frozen sections, and senolytic screening. This workflow combines the Cell Senescence β-Galactosidase Staining Kit with controls, quantitative imaging, and the Tp47–PKM2 mechanism to make senescent cell detection more reproducible.

• TerminaTOR Maps Nuclear mTORC1 Transcription

  2026-09-17

  Zhong and colleagues developed TerminaTOR, a genetically encodable inhibitor that selectively perturbs mTORC1 at defined subcellular locations. The study shows that lysosomal and nuclear mTORC1 support distinct outputs, with nuclear mTORC1 regulating transcription of CCAAT motif-containing genes.

• Palbociclib Workflow for Cell-Cycle Studies

  2026-09-16

  Build more informative CDK4/6 experiments with Palbociclib (PD0332991), combining dose-response, Rb-pathway verification, cell-cycle profiling, and apoptosis readouts. The workflow also adapts the ERCC1–p53 findings from lung cancer research into a practical framework for studying treatment response and resistance in breast, renal, and other cancer models.

• LY-411575 Gamma-Secretase Inhibitor Guide

  2026-09-16

  LY-411575 is a potent gamma-secretase inhibitor that suppresses amyloid beta production and Notch S3 cleavage in research assays. Its subnanomolar activity supports Alzheimer's disease research, while Notch-related effects require careful interpretation because the compound also produces pathway-associated toxicity signals in animal models.

• PDK4-IN-1 Hydrochloride: Assay-to-Mechanism

  2026-09-15

  PDK4-IN-1 hydrochloride is a selective pyruvate dehydrogenase kinase 4 inhibitor for linking PDH activation with mitochondrial energy metabolism. This guide presents an evidence-centered strategy for choosing target-engagement, metabolic-flux, and disease-model readouts.

• Naftifine HCl in Mechanism-Aware Antifungal Assays

  2026-09-15

  Naftifine HCl supports mechanism-focused dermatophyte experiments that connect sterol disruption with orthogonal growth and membrane readouts. This guide combines practical formulation guidance with assay-design lessons from WNT5a/GSK3/β-catenin research without implying that Naftifine HCl acts on that muscle pathway.

• YC-1: Practical Research Protocol and QC Guide

  2026-09-14

  YC-1 provides a research tool for examining hypoxia-related HIF-1α readouts alongside soluble guanylyl cyclase signaling in cellular and cancer research workflows. It is intended for controlled scientific experiments only; it should not be used as a diagnostic, therapeutic, or clinical product, and no universal potency or dosing claims should be inferred without model-specific validation.

• Tropisetron Hydrochloride: Transport Assay Guide

  2026-09-14

  Build receptor-signaling and renal transporter assays around Tropisetron Hydrochloride with concentration logic that separates 5-HT3 pharmacology from OCT2/MATE1 interference. This workflow translates a peer-reviewed cell-transport model into practical controls, dosing choices, and troubleshooting steps for neuroscience receptor modulation and drug–transporter research.

• Imatinib Hydrochloride: Assay Workflow & Troubleshooting

  2026-09-13

  Build reproducible kinase-inhibition assays with Imatinib hydrochloride, from DMSO stock preparation to pathway-level validation. This guide also shows how the reference study’s phosphatase-aware perspective can sharpen interpretation without overstating what the compound proves in cancer models.

• Benzyl Brassinosteroids in the Rice Lamina Test

  2026-09-12

  The reference study introduces seven C-22 benzyl brassinosteroid analogs and evaluates how fluorine or chlorine placement affects activity in the rice lamina inclination test. Its results show that replacing a benzoyl function with a benzyl group can reduce activity, whereas para-fluoro substitution substantially improves activity, providing a focused structure–activity framework for plant hormone research.

553 records 4/37 page Previous Next 12345 下5页 Last page